These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33995347)

  • 1. Uveitis: Molecular Pathogenesis and Emerging Therapies.
    Egwuagu CE; Alhakeem SA; Mbanefo EC
    Front Immunol; 2021; 12():623725. PubMed ID: 33995347
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Bian J; Wang K; Wang Q; Wang P; Wang T; Shi W; Ruan Q
    Front Immunol; 2020; 11():575669. PubMed ID: 33117376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology-based identification of the key mechanism of Qinghuo Rougan Formula acting on uveitis.
    Jing C; Sun Z; Xie X; Zhang X; Wu S; Guo K; Bi H
    Biomed Pharmacother; 2019 Dec; 120():109381. PubMed ID: 31542616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanisms in uveitis.
    Caspi RR
    Springer Semin Immunopathol; 1999; 21(2):113-24. PubMed ID: 10457585
    [No Abstract]   [Full Text] [Related]  

  • 5. [The status and prospects of immunological research in uveitis].
    Zheng YZ
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):277-80. PubMed ID: 23866710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells.
    Muhammad F; Avalos PN; Mursalin MH; Ma JX; Callegan MC; Lee DJ
    Front Immunol; 2020; 11():975. PubMed ID: 32508841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases.
    Bose T; Diedrichs-Möhring M; Wildner G
    Autoimmun Rev; 2016 Dec; 15(12):1181-1192. PubMed ID: 27639836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of biologics for the treatment of noninfectious uveitis.
    Takeuchi M
    Immunotherapy; 2013 Jan; 5(1):91-102. PubMed ID: 23256801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Inflammatory Diseases: Molecular Pathogenesis and Immunotherapy.
    Egwuagu CE; Sun L; Kim SH; Dambuza IM
    Curr Mol Med; 2015; 15(6):517-28. PubMed ID: 26238372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Biologic Therapies in Uveitis.
    Schwartzman S; Schwartzman M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):307-16. PubMed ID: 25431348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Privilege: The Microbiome and Uveitis.
    Mölzer C; Heissigerova J; Wilson HM; Kuffova L; Forrester JV
    Front Immunol; 2020; 11():608377. PubMed ID: 33569055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunology of the eye and its systemic interactions.
    Rocha G; Baines MG; Deschênes J
    Crit Rev Immunol; 1992; 12(3-4):81-100. PubMed ID: 1476622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.
    Impellizzeri D; Ahmad A; Bruschetta G; Di Paola R; Crupi R; Paterniti I; Esposito E; Cuzzocrea S
    Eur J Pharmacol; 2015 Aug; 761():28-35. PubMed ID: 25934566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat.
    de Vos AF; Klaren VN; Kijlstra A
    Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3873-83. PubMed ID: 7928184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding autoimmunity in the eye: from animal models to novel therapies.
    Caspi RR
    Discov Med; 2014 Mar; 17(93):155-62. PubMed ID: 24641958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy in ocular diseases].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1608-34. PubMed ID: 1283052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies in Development for Non-Infectious Uveitis.
    Sadiq MA; Agarwal A; Hassan M; Afridi R; Sarwar S; Soliman MK; Do DV; Nguyen QD
    Curr Mol Med; 2015; 15(6):565-77. PubMed ID: 26238367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
    Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
    Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneously relapsing-remitting experimental autoimmune uveitis in rats allows successful therapeutic oral tolerance induction in ongoing disease.
    Huber A; Diedrichs-Möhring M; Wildner G
    Mol Immunol; 2015 Feb; 63(2):215-26. PubMed ID: 25085538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.